Sign in

You're signed outSign in or to get full access.

Anne Busquet

Director at CareCloud
Board

About Anne Busquet

Anne M. Busquet (age 74) has served on CareCloud’s Board since July 2014 and is the Chairperson of the Audit Committee; the Board has designated her an “audit committee financial expert.” She is President of AMB Advisors, with over three decades of senior operating experience at American Express and IAC; she holds a BA from Cornell University and an MBA from Columbia University. Current external roles include director at Pitney Bowes and Elior Group, and trustee at Columbia Business School’s Board of Overseers and the French Institute Alliance Française. She is nominated for re‑election at the May 27, 2025 Annual Meeting.

Past Roles

OrganizationRoleTenureCommittees/Impact
American ExpressSenior leadership/executive rolesNot disclosed>30 years experience shaping financial services operations
IAC (Interactive Corp.)Executive rolesNot disclosedLed several successful businesses
Intercontinental Hotels GroupDirector (prior)Not disclosedBoard experience in hospitality
Blyth, Inc.Director (prior)Not disclosedBoard experience in consumer products

External Roles

OrganizationRolePublic/PrivateCommittee/Notes
Pitney BowesDirectorPublicCurrent board role
Elior GroupDirectorPublic (France)Current board role
Columbia University, Business School Board of OverseersTrusteeNon‑profit/AcademicGovernance oversight
French Institute Alliance FrançaiseTrusteeNon‑profitCultural institution governance

Board Governance

  • Independence: The Board determined Anne Busquet qualifies as an independent director under Nasdaq rules.
  • Committee roles: Audit Committee Chair; member of the full Board. Not listed as member of Compensation or Nominating/Corporate Governance; not on Cybersecurity subcommittee.
  • Audit expertise: Designated “audit committee financial expert”; Audit Committee is fully independent.
  • Meeting cadence and attendance: In 2024, Audit Committee held 5 meetings; Board held 5 meetings and acted by consent 7 times; each director attended at least 75% of Board and applicable committee/subcommittee meetings.
  • Election: Nominated for election at the May 27, 2025 Annual Meeting.

Fixed Compensation

Component (FY 2024)Amount (USD)
Fees Earned or Paid in Cash$58,000

Note: Busquet’s cash fees exceeded other non‑executive directors ($48,000), consistent with additional compensation for committee chair responsibilities; the proxy does not explicitly break out chair fee amounts.

Performance Compensation

ComponentDetailAmount/Units
Stock Awards (RSUs) vested in 2024Equity portion of annual director compensation$40,700
RSUs outstanding (12/31/2024)Unvested RSUs held45,000 units
RSU grant timing (Q3 2024)Automatic annual grant to outside directors30,000 RSUs each
Vesting schedule (Q3 2024 grant)25% increments over next two years beginning Feb 2025As disclosed (no specific dates beyond start)

Mix (FY 2024): Cash $58,000 vs equity $40,700, implying ~59% cash / ~41% equity; plus unvested RSUs indicate increasing equity alignment into 2025–2026.

Other Directorships & Interlocks

CompanyRolePotential Interlock/Conflict with CCLD
Pitney BowesDirectorNo supplier/customer/competitor linkage disclosed in proxy
Elior GroupDirectorNo linkage disclosed in proxy
Intercontinental Hotels Group (prior)DirectorHistorical role; no linkage disclosed
Blyth, Inc. (prior)DirectorHistorical role; no linkage disclosed

Expertise & Qualifications

  • Financial oversight: Audit Committee Chair with “financial expert” designation; experienced in internal controls, auditor oversight, and financial reporting.
  • Operating background: Decades of senior experience scaling businesses at American Express and IAC.
  • Education: Cornell University (BA) and Columbia University (MBA).

Equity Ownership

HolderCommon Shares Beneficially Owned% of ClassSeries B PreferredNotes
Anne M. Busquet266,3880.6%Beneficial ownership per SEC rules (includes shares acquirable within 60 days)
RSUs outstanding (12/31/2024)45,000Unvested RSUs outstanding
  • Hedging/pledging: Insider Trading Policy prohibits hedging, short sales, and pledging; limited exceptions for pledging require prior approval and demonstrated capacity to repay without resort to pledged shares. Proxy does not disclose any pledges by directors.
  • Ownership guidelines: No director stock ownership guideline disclosure found in proxy; non‑employee directors receive automatic initial/annual RSU grants per policy.

Governance Assessment

  • Positive signals:

    • Independent Audit Chair with SEC “financial expert” designation; committee is fully independent.
    • Demonstrated engagement: Audit Committee met 5 times in 2024; each director met ≥75% attendance threshold.
    • Material personal ownership: 266,388 common shares (0.6% of outstanding), plus 45,000 RSUs outstanding, supports alignment with shareholders.
    • Clear insider trading controls (10b5‑1 permitted plans; anti‑hedging/pledging policy).
  • Watch items / potential red flags:

    • Related‑party transactions involving the Executive Chairman (leases, physician‑customer relationship) create heightened oversight demands for the Audit Committee; ongoing monitoring and robust controls are essential.
    • Multiple external commitments (Pitney Bowes, Elior Group, trustee roles) increase time demands; however, the proxy reports ≥75% attendance for all directors in 2024.
  • Compensation structure observations:

    • FY 2024 director pay combined cash ($58k) and equity ($40.7k); additional RSU grants in Q3 2024 vest through 2026, reinforcing equity alignment. No performance metrics tied to director RSUs disclosed (service‑based vesting).
  • Independence and conflicts:

    • Board explicitly affirms Busquet’s independence under Nasdaq rules; no Busquet‑specific related‑party transactions disclosed.